{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:53:47Z","timestamp":1765727627873,"version":"3.41.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1023\/a:1006455526894","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T02:03:28Z","timestamp":1040522608000},"page":"33-43","source":"Crossref","is-referenced-by-count":23,"title":["p21WAF1\/CIP1 Expression in breast cancers: associations with p53 and outcome"],"prefix":"10.1007","volume":"61","author":[{"given":"Ann D.","family":"Thor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuquing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan H.","family":"Moore II","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuju","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Edgerton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"264046_CR1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/02841869009090009","volume":"293","author":"IT Ernberg","year":"1990","unstructured":"Ernberg IT: Oncogenes and tumor growth factors in breast cancer. A minireview. Acta Oncol 29(3): 331\u2013334, 1990","journal-title":"A minireview. Acta Oncol"},{"key":"264046_CR2","first-page":"1","volume":"90","author":"AD Thor","year":"1998","unstructured":"Thor AD, Berry DA, Budman DR, Muss HB, Kute T, Henderson IC, Barcos M, Cirrincione C, Edgerton S, Allred C, North L, Liu ET: erbB-2, p53 and the efficacy of adjuvant therapy in lymph node positive breast cancer. J Natl Cancer Inst 90: 1\u201316, 1998","journal-title":"J Natl Cancer Inst"},{"key":"264046_CR3","first-page":"106","volume":"4","author":"M Barbareschi","year":"1996","unstructured":"Barbareschi M: Prognostic value of the immunohistochemical expression of p53 in breast carcinomas: a review of the literature involving over 9000 patients. Applied Immunohistochemistry 4: 106\u2013116, 1996","journal-title":"Applied Immunohistochemistry"},{"key":"264046_CR4","first-page":"2250","volume":"56","author":"ER McDonald III","year":"1996","unstructured":"McDonald ER III, Wu GS, Waldman T, El-Deiry W: Repair defect in p21 WAF1\/CIP1 \u2013\/\u2013 human cancer cells Cancer Res 56: 2250\u20132255, 1996","journal-title":"Cancer Res"},{"key":"264046_CR5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1126\/science.8153613","volume":"264","author":"J Marx","year":"1994","unstructured":"Marx J: New tumor suppressor may rival p53. Science 264: 344\u2013345, 1994","journal-title":"Science"},{"key":"264046_CR6","first-page":"15","volume":"149","author":"J Geradts","year":"1996","unstructured":"Geradts J, Wilson PA: High frequency of aberrant p16 (INK4A) expression in human breast cancer. Am J Pathol 149: 15\u201320, 1996","journal-title":"Am J Pathol"},{"issue":"2","key":"264046_CR7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nm0297-222","volume":"3","author":"PL Porter","year":"1997","unstructured":"Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM: Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3(2): 222\u2013225, 1997","journal-title":"Nat Med"},{"issue":"2","key":"264046_CR8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nm0297-227","volume":"3","author":"C Catzavelos","year":"1997","unstructured":"Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI, Slingerland JM: Decreased levels of the cell-cycle inhibitor p27Kipl protein: prognostic implications in primary breast cancer. Nat Med 3(2): 227\u2013230, 1997","journal-title":"Nat Med"},{"issue":"2","key":"264046_CR9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nm0297-231","volume":"3","author":"M Loda","year":"1997","unstructured":"Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup M, Pagano M: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 3(2): 231\u2013234, 1997","journal-title":"Nat Med"},{"issue":"2","key":"264046_CR10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nm0297-152","volume":"3","author":"PS Steeg","year":"1997","unstructured":"Steeg PS, Abrams JS: Cancer prognostics: past, present and p27. Nat Med 3(2): 152\u2013154, 1997","journal-title":"Nat Med"},{"key":"264046_CR11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/jnci\/84.11.845","volume":"84","author":"AD Thor","year":"1992","unstructured":"Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch FIT, Marcus JN, Schwartz L, Chen LC, Mayall BH, Smith HS: Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84: 845\u2013855, 1992","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"264046_CR12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/bjc.1995.399","volume":"72","author":"M Stenmark-Askmalm","year":"1995","unstructured":"Stenmark-Askmalm M, Stal O, Olsen K, Nordenskjold B: p53 as a prognostic factor in stage I breast cancer. South-East Sweden Breast Cancer Group. Br J Cancer 72(3): 715\u2013719, 1995","journal-title":"Br J Cancer"},{"issue":"1","key":"264046_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/bjc.1996.316","volume":"74","author":"SC Linn","year":"1996","unstructured":"Linn SC, Honkoop AH, Hoekman K, van der Valk P, Pinedo HM, Giaccone G: p53 and P-glycoprotein are often coexpressed and are associated with poor prognosis in breast cancer. Br J Cancer 74(1): 63\u201368, 1996","journal-title":"Br J Cancer"},{"issue":"2","key":"264046_CR14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/(SICI)1096-9098(199606)62:2<86::AID-JSO3>3.0.CO;2-M","volume":"62","author":"DD Patel","year":"1996","unstructured":"Patel DD, Bhatavdekar JM, Chikhlikar PR, Ghosh N, Suthar TP, Shah NG, Mehta RH, Balar DB: Node negative breast carcinoma: hyperprolactinemia and\/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators. J Surg Oncol 62(2): 86\u201392, 1996","journal-title":"J Surg Oncol"},{"issue":"3","key":"264046_CR15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1073\/pnas.93.3.1093","volume":"93","author":"JS Kovach","year":"1996","unstructured":"Kovach JS, Hartmann A, Blaszyk H, Cunningham J, Schaid D, Sommer SS: Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proc Natl Acad Sci USA 93(3): 1093\u20131096, 1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"264046_CR16","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/ajcp\/107.6.684","volume":"107","author":"E Wakasugi","year":"1997","unstructured":"Wakasugi E, Kobayashi T, Tamaki Y, Ito Y, Miyashiro I, Komoike Y, Takeda T, Shin E, Takatsuka Y, Kikkawa N, Monden T, Monden M: p21 (Waf1\/Cip1) and p53 protein expression in breast cancer. Am J Clin Pathol 107(6): 684\u2013691, 1997","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"264046_CR17","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/bjc.1993.383","volume":"68","author":"TI Andersen","year":"1993","unstructured":"Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L, Brresen AL: Prognostic significance of TP53 alterations in breast carcinoma. Br J Cancer 68(3): 540\u2013548, 1993","journal-title":"Br J Cancer"},{"key":"264046_CR18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/366701a0","volume":"366","author":"Y Xiong","year":"1993","unstructured":"Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366: 701\u2013704, 1993","journal-title":"Nature"},{"issue":"5","key":"264046_CR19","first-page":"1169","volume":"54","author":"WS EI-Deiry","year":"1994","unstructured":"EI-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Winman KG, Mercer WE, Kastan MB, Kohn K, Elledge SJ, Kinzier KW, Vogeistein B: WAF-1\/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54(5): 1169\u20131174, 1994","journal-title":"Cancer Res"},{"issue":"1","key":"264046_CR20","first-page":"167","volume":"150","author":"J Lukas","year":"1997","unstructured":"Lukas J, Groshen S, Saffari B, Nui N, Reles A,WenWH, Felix J, Johns LA, Hall FL, Press MF:WAF1\/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Am J Pathol 150(1): 167\u2013175, 1997","journal-title":"Am J Pathol"},{"key":"264046_CR21","first-page":"3407","volume":"9","author":"MS Sheikh","year":"1994","unstructured":"Sheikh MS, Li XS, Chen JC, Shao ZM, Ordonez JV, Fontana JA: Mechanisms of regulation of WAF1\/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9: 3407\u20133415, 1994","journal-title":"Oncogene"},{"issue":"13","key":"264046_CR22","first-page":"3391","volume":"54","author":"P Michieli","year":"1994","unstructured":"Michieli P, Chedid M, Lin D, Pierec JH, Mercer WE, Givol D: Induction of WAF1\/CIP1 by a p53-independent pathway. Cancer Res 54(13): 3391\u20133395, 1994","journal-title":"Cancer Res"},{"issue":"4","key":"264046_CR23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/bjc.1997.413","volume":"76","author":"PA Ellis","year":"1997","unstructured":"Ellis PA, Lonning PE, Borresen-Dale A, Aas T, Geisler S, Akslen LA, Salter I, Smith IE, Dowsett M: Absence of p21 expression is associated with abnormal p53 in human breast carcinomas. Br J Cancer 76(4): 480\u2013485, 1997","journal-title":"Br J Cancer"},{"key":"264046_CR24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/381713a0","volume":"381","author":"T Waldman","year":"1996","unstructured":"Waldman T, Lengauer C, Kinzler KW, Vogelstein B: Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381: 713\u2013716, 1996","journal-title":"Nature"},{"key":"264046_CR25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.7973635","volume":"266","author":"SW Lowe","year":"1994","unstructured":"Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T: p53 status and the efficacy of cancer therapy in vivo. Science 266: 807\u2013813, 1994","journal-title":"Science"},{"issue":"20","key":"264046_CR26","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/jnci\/88.20.1442","volume":"88","author":"CC Harris","year":"1996","unstructured":"Harris CC: Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88(20): 1442\u20131455, 1996","journal-title":"J Natl Cancer Inst"},{"key":"264046_CR27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1005752829260","volume":"43","author":"SG Diab","year":"1997","unstructured":"Diab SG, Yu YY, Hilsenbeck SG, Allred DC, and Elledge RM: WAF1\/CIP1 protein expression in human breast tumors. Breast Cancer Res Treat 43: 99\u2013103, 1997","journal-title":"Breast Cancer Res Treat"},{"key":"264046_CR28","first-page":"127","volume-title":"Manual for Staging of Cancer","year":"1983","unstructured":"Beahrs OH, Myers MH (eds), Manual for Staging of Cancer, 2nd edn, pp. 127\u2013133 Philadelphia: Lippincott, 1983","edition":"2nd edn"},{"issue":"5","key":"264046_CR29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathol 19(5): 403\u2013410, 1991","journal-title":"Histopathol"},{"key":"264046_CR30","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1200\/JCO.1999.17.2.470","volume":"17","author":"AD Thor","year":"1999","unstructured":"Thor AD, Liu S, Moore HD II, Edgerton SM: Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer. J Clin Oncol 17: 470\u2013477, 1999","journal-title":"J Clin Oncol"},{"key":"264046_CR31","first-page":"46","volume":"10","author":"C Benz","year":"1991","unstructured":"Benz C, Thor A, Edgerton S, He M, Liu E: HER2\/neu overexpression and gene amplification in comedo-type in situ breast cancers. Proc ASCO 10: 46, 1991","journal-title":"Proc ASCO"},{"key":"264046_CR32","first-page":"1027","volume":"7","author":"E Liu","year":"1992","unstructured":"Liu E, Thor A, He M, Barcos M, Ljung B-M, Benz C: The HER-2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene 7: 1027\u20131032, 1992","journal-title":"Oncogene"},{"key":"264046_CR33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR: Regression models and life-tables. J R Statist Soc Ser B 34: 187\u2013220, 1972","journal-title":"J R Statist Soc Ser B"},{"key":"264046_CR34","first-page":"461","volume-title":"Diseases of the Breast","author":"GM Clark","year":"1996","unstructured":"Clark GM: Prognostic and predictive factors. In: Harris JR, Heilman S, Lippman M, Morrow M, (eds) Diseases of the Breast. Philadelphia, Lippincott-Raven, 1996, 461\u2013485"},{"key":"264046_CR35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"P Grambsch","year":"1994","unstructured":"Grambsch P, Therneau TM: Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81: 515\u2013526, 1994","journal-title":"Biometrika"},{"key":"264046_CR36","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","volume":"274","author":"CJ Sheer","year":"1996","unstructured":"Sheer CJ: Cancer cell cycles. Science 274: 1672\u20131677, 1996","journal-title":"Science"},{"issue":"13","key":"264046_CR37","first-page":"2910","volume":"55","author":"WS EI-Deiry","year":"1995","unstructured":"EI-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW, Vogelstein B: Topological control of p21WAF1=CIP1 expression in normal and neoplastic tissues. Cancer Res 55(13): 2910\u20132919, 1995","journal-title":"Cancer Res"},{"key":"264046_CR38","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/369574a0","volume":"369","author":"S Waga","year":"1994","unstructured":"Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574\u2013578, 1994","journal-title":"Nature"},{"key":"264046_CR39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","volume":"358","author":"DP Lane","year":"1992","unstructured":"Lane DP: Cancer. p53, guardian of the genome. Nature 358: 15\u201316, 1992","journal-title":"Nature"},{"key":"264046_CR40","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/jnci\/84.11.826","volume":"84","author":"R Callahan","year":"1992","unstructured":"Callahan R: p53 mutations, another breast cancer prognostic factor. J Natl Cancer Inst 84: 826\u2013827, 1992","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"264046_CR41","first-page":"145","volume":"140","author":"PL Porter","year":"1992","unstructured":"Porter PL, Gown AM, Kramp SG, Coltrera MD: Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue. Am J Pathol 140(1): 145\u2013153, 1992","journal-title":"Am J Pathol"},{"issue":"10","key":"264046_CR42","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nm1095-1052","volume":"1","author":"ZY Yang","year":"1995","unstructured":"Yang ZY, Perkins ND, Ohno T, Nabel EG, Nabel GJ: The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nat Med 1(10): 1052\u20131056, 1995","journal-title":"Nat Med"},{"key":"264046_CR43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/381643a0","volume":"381","author":"T Jacks","year":"1996","unstructured":"Jacks T, Weinberg RA: Cell-cycle control and its watchman. Nature 381: 643\u2013644, 1996","journal-title":"Nature"},{"issue":"14","key":"264046_CR44","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/jnci\/84.14.1109","volume":"84","author":"J Isola","year":"1992","unstructured":"Isola J, Visakorpi T, Holli K, Kallioniemi OP: Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 84(14): 1109\u20131114, 1992","journal-title":"J Natl Cancer Inst"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006455526894.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006455526894\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1006455526894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006455526894.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:26:58Z","timestamp":1750480018000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006455526894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["264046"],"URL":"https:\/\/doi.org\/10.1023\/a:1006455526894","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}